From: Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk
Procoagulant state | Number of patients in study group | TEG version | Data range in control group, mean ± SD unless otherwise indicated | Data range in group with hypercoagulation, mean ± SD unless otherwise indicated | Significance | Predictive value | Reference | Comments |
---|---|---|---|---|---|---|---|---|
Patients with acute ischemic stroke | 93-Unfavorable outcome evaluatewd by modified Rankin Scale within a year 91-Favorable outcome | Citrate plasma was mixed with kaolin, and loaded in a heparinise-coated cup | means ± SE MA, mm 63.2 ± 0.5 | means ± SE MA, mm 66.1 ± 0.6 | <0.001 | Prediction of unfavorable outcome At higher tertile of MA OR = 1.192 | [92] | Prospective study. |
Postoperative Thrombotic Complications | 240 patients undergoing a wide variety of surgical procedure s, 10 thrombotic complications | celite-activated TEG on native blood samples within 4 min of collection | MA 66 ± 9 | MA 71 ± 9 |  |  | [103] | Prospective study. Thromboelastography was performed immediately after surgery. |
6 myocardial infarction |  | MA 66 ± 9 | MA 74 ± 5 |  | OR = 1.16 | |||
Postoperative Thrombotic Complications | 152 critically ill patients in the surgical intensive care unit 16 thrombotic complications | native blood, rTEG(activation with kaolin, human recombinant TF, phospholipids) |  |  |  | G > 12.4 dynes/cm OR = 1.25 | [104] |  |
Normal pregnancy | 65/65 | Recalcified citrate plasma | R, min 7.8 ± 2.5 | R, min 6.1 ± 1.8 | <0.001 |  | [102] |  |
K, min 2.7 ± 2.3 | K, min 1.4 ± 0.5 | |||||||
Alfa, deg 57.7 ± 11.6 | Alfa, deg 70.6 ± 6.5 | |||||||
MA, mm 61 ± 5.9 | MA, mm 71 ± 3.8 | |||||||
Ly 30, % 0.8 ± 1.7 | Ly 30, % 0.3 ± 0.7 |